"Focus on Emerging Industries & Startups." The military has yet to test Nisin o

Authors

Sam Smith

Source

Mainebiz

Date

1-7-2002

Pages

1, 16-17

Abstract

"Focus on Emerging Industries & Startups." The military has yet to test Nisin on anthrax bacteria, but ImmuCell's stock has rapidly risen even above its previous successes treating human diarrhea and bovine sicknesses. Nisin is a broad-spectrum antibacterial, meaning it treats a large number of illnesses. Details.

Subjects

Anthrax, Biotechnology industries, ImmuCell Corp Portland

Full text is not available here. Please contact the Library for a copy of the article.

Share

COinS